# OXAZEPAM

NDC: 69315-912
Generic name: OXAZEPAM
Labeler / Manufacturer: Leading Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250709

FDA application: ANDA218261

## Active ingredients

- OXAZEPAM: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69315-912"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69315-912
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67f821fa-5663-4d69-82c9-5ee13a09f324